MedTrace Logo

Misoprostol With Intrauterine Device Insertion

NCT00613366 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-03-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see if using misoprostol (a medication that softens the cervix) before placing an intrauterine device for contraception reduces pain in women who have never delivered a baby.

Conditions

  • Contraception

Interventions

DRUG

Misoprostol

Place 2 tablets between the teeth and cheek and allow to dissolve for 30 minutes.

DIETARY_SUPPLEMENT

Magnesium Oxide

Place 2 tablets between the teeth and cheek and allow to dissolve for 30 minutes.

Sponsors & Collaborators

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Alison Edelman, M.D., M.P.H · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2010-04-30
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00613366 on ClinicalTrials.gov